A proprietary tool utilized by GlaxoSmithKline (GSK), the application enables prediction and assessment of the degradation rate of their vaccines under varying storage conditions. This computational instrument aids in determining the shelf life and optimal storage parameters for maintaining product potency and safety. It incorporates a range of data inputs, including formulation characteristics and results from accelerated stability studies.
The tool provides significant advantages in vaccine development and distribution. By predicting degradation, it helps ensure vaccine efficacy is maintained throughout the supply chain, minimizing waste and protecting public health. Historically, assessing vaccine stability relied heavily on lengthy real-time studies. This digital solution offers a more efficient method, expediting the process of bringing new and improved vaccines to market and also allows for risk mitigation in varying geographies.
